Marshall Wace LLP decreased its position in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 80.2% during the 2nd ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

GSK paid $22.4 million on Sept. 27 for 2.8 million more shares of Wave Life Sciences for $8 each. GSK now owns 16.8 million ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Zantac was pulled from shelves in 2019 amid panic that a key ingredient - ranitidine - could cause cancer, plunging GSK and ...

Investing.com-- U.S. stock index futures rose slightly in evening deals on Thursday after hotter-than-expected consumer ...

EUROPEAN shares closed lower on Thursday (Oct 10), with defence and industrial stocks leading losses, after data showed US inflation ticked higher, while investors waited for France to unveil its 2025 ...

Europe: Shares waver ahead of U.S. CPI as GSK soars on court settlement European stocks slid ... Japan: Nikkei edges up as ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

UK stocks saw mixed performances as dividend exclusions weighed on some major companies, while GSK shares surged post-lawsuit ...